MARA RIMINUCCI

Mara Riminucci

Education and Training
1999-2022 (intermittent) Visiting Fellow, Craniofacial and Skeletal Diseases Branch, NIDCR, NIH, Bethesda, MD; 1997-1999 Fellowship Fondazione Telethon Italia, Department of Experimental Medicine, University of L’Aquila, Italy; 1995-1997 Fogarty International Fellowship, Clinical Studies Program, Craniofacial and Skeletal Diseases Branch, NIDCR, NIH, Bethesda, MD; 1997 PhD Human Pathology , Sapienza University of Rome, Italy; 1993 Board Certified Anatomic pathology, Sapienza University of Rome, Italy; 1989 MD cum laude, Sapienza University of Rome, Italy

Academic positions
2016- Professor, Anatomic pathology, Sapienza University of Rome, Italy; 2007-2016 Associate Professor, Sapienza University of Rome, Italy; 2002-2007 Associate Professor, University of L’Aquila, Italy; 1999-2002 Assistant Professor, University of L’Aquila, Italy

Clinical positions
2020- Clinical Program: Advanced Diagnostic in Skeletal Displasias; 2010- Anatomic pathology, Policlinico Umberto I University Hospital, Rome, Italy; 2002-2003 (intermittent)Expert Consultant, Clinical Protocols on Fibrous dysplasia, Craniofacial and Skeletal Diseases Branch, NIDCR, NIH, Bethesda, MD

Research grants
2023 Italian Government, Department University and Research; 2023 MDBR-Orphan Disease Center, University of Pennsylvania; 2021 MDBR-Orphan Disease Center, University of Pennsylvania; 2020 Sapienza University; 2019 Sapienza University; 2019 MDBR-Orphan Disease Center, University of Pennsylvania; 2018 Istituto Pasteur-Fondazione Cenci Bolognetti “Seed International Research Projects”; 2018 MDBR-Orphan Disease Center, University of Pennsylvania; 2017 MDBR-Orphan Disease Center, University of Pennsylvania; 2016 MDBR-Orphan Disease Center, University of Pennsylvania; 2015 Telethon; 2015 EC 7th Framework Grant Agreement HEALTH.2013.1.4-1 (Unit PI); 2015 Sapienza University; 2015 Istituto Pasteur-Fondazione Cenci Bolognetti; 2008 Fondazione Roma (Unit PI); 2008 Italian Government, Department of Health (Unit PI); 2006 Italian Government, Department University and Research; 2003 Italian Government, Department University and Research (Unit PI); 2001 Italian Government, Department University and Research

Awards
2009 Telethon award; 1998 America Society for Bone and Mineral Research; 1998 International Bone and Mineral Society; 1997 SIAPEC-Italian Academy of Pathology; 1996 National Institute of Dental and Craniofacial Research, NIH; 1989 MURST

Scientific Societies
2022-2023 The American Society for Bone and Mineral Research; 2021- International Bone Marrow Adiposity Society, Boards Alumni Member; 2018-2021 International Bone Marrow Adiposity Society, Founder Team and Executive Board Member; 2015- Medical Academy of Rome, Academic Member

Editorial Boards
2020- Calcified Tissue International – Editorial Board; 2016- Stem Cell Research- Editorial Board; 2008- F1000 Invited faculty member

Meeting organization
2025 International FD/MAS Consortium, Madrid, Spain (session chair); 2023 International FD/MAS Consortium, Silver Spring, MD, USA (session chair); 2017 3rd International Bone Marrow Adiposity Meeting 2017, Lausanne, Switzerland (co-organizer)

Reviewer activity
Journals > 50 scientific and medical journals including: Nature, Cell Death and Differentiation, Bone Research, Theranostics, Journal of Clinical Investigation Insight, Stem Cells, Stem Cells Translational Medicine, Journal of Cellular and Molecular Medicine, Bone, American Journal of Pathology, Journal of Dental Research, European Journal of Endocrinology, Journal of Bone and Mineral Research, Calcified Tissue International, JCI Insight.
H1 Connect (Faculty 1000)
Agencies European Science Foundation, Medical Research Council, Swiss National Science Foundation, European Calcified Tissue Society, French National Research Agency, Czech Science Foundation, Cure Kids, Swiss 3R Competence Centre, Sapienza University Intramural.

Invited lectures
2025 Espe-Oscar Science Symposium, Paris, France; 2025 European Calcified Tissue Society, Annual Meeting, Innsbruck, Austria; 2024 University of Rome Tor Vergata, Rome, Italy; 2023 Fibrous Dysplasia/McCune-Albright Syndrome: Celebrating 25 Years of NIDCR Research, Bethesda, MD, USA; 2023 Hot Topics: Malattie dell’osso in età pediatrica, Rome, Italy; 2023 SIOMMMS XXIII National Meeting, Messina, Italy; 2022 Workshop: Translational research on bone impairment in rare diseases, Lyon, France; 2022 American Society for Bone and Mineral Research, Annual Meeting, Austin, TX, USA. 2021 European Calcified Tissue Society, Annual Meeting (digital); 2021 BMAS Summer School (digital); 2021 University of Palermo (digital); 2021 FD/MAS Alliance Research Update (digital); 2020 European Calcified Tissue Society, Annual Meeting, Working Group on Mammalian models (digital); 2020 European Calcified Tissue Society, Annual Meeting, Symposium on Fundamentals and clinical consequences of bone marrow adiposity (digital); 2019 FD/MAS Consortium 4th Meeting. Florence, Italy; 2019 GISM Annual Meeting, Genova, Italy; 2019 Osteopatie Metaboliche in Età Pediatrica, 1° National Meeting. Rome, Italy; 2018 Dutch Society for Calcium and Bone Metabolism 28th Annual Meeting. Zeist, Netherlands; 2018 Winter School of ROAD Network. Paris, France; 2017 Eamas, VII Meeting. Arezzo, Italy; 2017 Paracelsus, SCI-TReCS. Salzburg, Austria; 2017 Fibrous Dysplasia Foundation Conference. Silver Spring, MD; 2017 International FD/MAS Consortium, 3rd Meeting. Leiden, Netherlands; 2016 2nd Bone Marrow Adiposity Meeting, Rotterdam, Netherlands; 2016 29th Annual Conference of Italian Association of Cell Cultures. Crossroads in cellular and molecular biotechnology, L’Aquila, Italy; 2013 International Cartilage Repair Society (ICRS), 11° World Congress, Izmir, Turkey; 2013 HEMO 2013, The biology of stem cells (MSC), Brasilia, Brazil; 2013 HEMO 2013, Critical evaluation of cell therapy (specially MSC), Brasilia, Brazil; 2013 SIOMMMS XII National Meeting, Bologna, Italy; 2012 Giornata di aggiornamento sul Linfoma di Hodgkin, Roma, Italy; 2012 Immunopathology and orphan diseases, 15° Meeting, Torino, Italy; 2011 Unistem, Rome, Italy; 2011 Osteotropic cancer: new pathogenetic and clinical aspects, Bari, Italy; 2011 University of Udine, Udine, Italy; 2011 Rome Elbow 2011, Rome, Italy; 2011 Medicina Rigenerativa: attualità e prospettive, Rome, Italy; 2011 Fibrousdysplasia Ossificans Progressiva, 5th Meeting, Rome, Italy; 2010 Patologia immune e malattie orfane, 13° Meeting, Torino, Italy; 2010 IAP Italian Division, Bologna, Italy; 2010 International Meeting on FD/MAS and Cherubism: Best Clinical Practice and Future Research. Bethesda, MD; 2009
Stem cells and wound healing,Turku, Finland; 2009 Regenerative Surgery 1st International Conference, Rome, Italy; 2008 Gordon Research Conference "Biomineralization" New London, NH; 2008 Accademia Medica, Roma, Italy; 2008 2nd Course in Clinical Dismorphology, Forlì, Italy; 2008 IES, 3° Meeting, Roma, Italy; 2008 Italian Society of Cytometry, XXVI Meeting, Urbino, Italy; 2008 Mediterranean School of Oncology, Molecular mechanism of bone formation and regeneration, Rome, Italy; 2008 Mediterranean School of Oncology, Osteodysplasias, Rome, Italy; 2008 1st Advances in Rare Bone Diseases Conference, Washington, DC; 2007 SIMO, Roma Italy; 2005Meeting on Biological and Clinical Behavior of Fibro-osseous Diseases with Oral Manifestation. Toulouse, France; 2005 SIAPEC IAP, National Meeting, Chieti, Italy; 2005 Genetics, Biochemistry and Physiology of NDP Kinase NM23 AWD and other metastasis suppressor genes and functions, International Congress, Naples, Italy; 2005 SIFC, 1° National Meeting, Rome, Italy; 2004 Genostem, Tours, France; 2002 IAP Italian Division, Treviso, Italy; 2002 VI International Symposium on Adesive and Reconstructive Dentistry, S. Margherita Ligure, Italy; 2000 European Pediatric Orthopedic Society, Milan, Italy; 2000 Gordon Research Conference, Matrix Metalloproteases, Lucca, Italy; 1997 Gordon Research Conference, Cellular and Molecular Biology of Bones and Teeth, Meriden, NH

Webinars
2025 FD/MAS Alliance Research update; 2024 Care4Bones; 2023 FD/MAS Alliance Research Update; 2021 FD/MAS Research update; 2019 Stem Cell Technologies

Commentaries on published work
1) Singer FR: Commentary: Fibrous dysplasia of bone: the bone lesion unmasked. Am J Pathol 151: 1511 1515,1997;
2) Olsen BR: Editorial: "A rare disorder, yes. An unimportant one, never" J Clin Invest 101: 1545-1546, 1998;
3) Quarles LD: Commentary: “Evidence for a bone-kidney axis regulating phosphate Homeostasis”. J Clin Invest 112: 642-646, 2003;
4) Janet T. Powell and Toste Länne "Through Thick and Thin Collagen Fibrils, Stress, and Aortic Rupture: Another Piece in the Jigsaw". Circulation 2007 115: 2687 - 2688, doi:10.1161/CIRCULATIONAHA.107.709139;
5) J Clin Invest 101(8), 1998- Cover Story;
6) National Institutes of Health - Press release April 14, 1998;
7) OMIM #174800 MCCUNE-ALBRIGHT SYNDROME, MAS; #139320 GNAS COMPLEX LOCUS, GNAS; #166260 GNATHODIAPHYSEAL DYSPLASIA, GGD; #166250 OSTEOGLOPHONIC DYSPLASIA, OGD; #136350 FIBROBLAST GROWTH FACTOR RECEPTOR1 FGFR1;
8) De Castro LF, Boyce AM, Collins MT Editorial: First in Mice: RANKL Neutralization in Fibrous Dysplasia. J Bone Miner Res 2019 DOI: 10.1002/jbmr.3904

Bibliography

Articles peer-reviewed 191
Article in Italian 4
Chapters 16

Scopus https://www.scopus.com/authid/detail.uri?authorId=7003835803
Citation 12062
h-index 48